Program Monitoring
6,925
Number of Clinics
54,882
Number of Settlements
4,884,882
Enrollments
20,441,250
Disbursements
Bauchi
1,109
9,325
690,871
2,939,113
Gombe
518
5,128
314,771
1,329,464
Jigawa
785
7,502
888,793
4,069,347
Kaduna
276
2,123
199,637
747,037
Kano
1,260
11,566
952,277
3,714,631
Katsina
1,296
6,509
1,042,489
4,694,168
Kebbi
540
3,004
217,643
809,857
Niger
331
2,754
30,704
45,044
Sokoto
380
2,936
198,040
750,960
Yobe
158
1,762
34,568
52,214
Zamfara
272
2,273
315,089
1,289,415
Vaccination Rate
95.61%
Penta 1
91.22%
Penta 2
88.25%
Penta 3
85.75%
Measles
Bauchi
95.48%
91.48%
88.67%
85.75%
Gombe
96.24%
92.9%
90.29%
87.45%
Jigawa
95.8%
92.42%
90.3%
87.77%
Kaduna
95.46%
90.58%
87.03%
82.57%
Kano
94.98%
91.03%
88.07%
84.78%
Katsina
96.21%
92.67%
90.37%
88.15%
Kebbi
95.08%
88.62%
84.35%
82.54%
Niger
93.19%
83.2%
76.29%
86.47%
Sokoto
94.25%
84.07%
77.91%
74.54%
Yobe
94.83%
89.88%
85.22%
92.73%
Zamfara
96.32%
88.73%
83.72%
83.4%
Impact Evaluation Key Findings
An independent randomized controlled trial found, among other positive findings, that New Incentives’ All Babies program:
Increased Coverage
The program doubled the percentage of infants who were fully vaccinated, increasing coverage from roughly a quarter to just over half of all infants.
Improved Timeliness
Infants who received measles vaccines were 33 percentage points more likely to receive the vaccine within one month of the recommended age.
Improved Knowledge and Attitudes
Caregivers in areas served by the program had better knowledge and more favorable attitudes toward immunization.
Reduced Stockouts
Government clinics with the program were 18 percentage points less likely to report vaccine stockouts during the last 12 months.
Randomized Controlled Trial
Expected in Dec 2020
Study with two-arm cluster RCT
- Control (83 clinics): No intervention, status quo
- Treatment (84 clinics): New Incentives full program
- This design will measure the causal effect of New Incentives' program on the likelihood of an infant receiving a vaccine.
.svg)
.svg)
.png)